Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study

Umut Kirli*, Tolga Binbay, Marjan Drukker, Hayriye Elbi, Bulent Kayahan, Duygu Keskin Gokcelli, Ferda Ozkinay, Huseyin Onay, Koksal Alptekin, Jim van Os

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)113-121
Number of pages9
JournalAmerican Journal of Medical Genetics Part B-neuropsychiatric Genetics
Volume180
Issue number2
DOIs
Publication statusPublished - Mar 2019

Keywords

  • AGE
  • BDNF
  • BDNF GENE
  • BIPOLAR DISORDER
  • CANDIDATE GENES
  • NEUROTROPHIC FACTOR VAL66MET
  • ONSET
  • RECEPTOR
  • RISK
  • SCHIZOPHRENIA
  • SYMPTOMS
  • environmental factors
  • epidemiology
  • extended psychosis phenotype
  • transdiagnostic psychosis phenotype

Cite this

Kirli, Umut ; Binbay, Tolga ; Drukker, Marjan ; Elbi, Hayriye ; Kayahan, Bulent ; Gokcelli, Duygu Keskin ; Ozkinay, Ferda ; Onay, Huseyin ; Alptekin, Koksal ; van Os, Jim. / Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study. In: American Journal of Medical Genetics Part B-neuropsychiatric Genetics. 2019 ; Vol. 180, No. 2. pp. 113-121.
@article{65e9c34368944d3c9ecffd231fe26e8a,
title = "Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study",
keywords = "AGE, BDNF, BDNF GENE, BIPOLAR DISORDER, CANDIDATE GENES, NEUROTROPHIC FACTOR VAL66MET, ONSET, RECEPTOR, RISK, SCHIZOPHRENIA, SYMPTOMS, environmental factors, epidemiology, extended psychosis phenotype, transdiagnostic psychosis phenotype",
author = "Umut Kirli and Tolga Binbay and Marjan Drukker and Hayriye Elbi and Bulent Kayahan and Gokcelli, {Duygu Keskin} and Ferda Ozkinay and Huseyin Onay and Koksal Alptekin and {van Os}, Jim",
year = "2019",
month = "3",
doi = "10.1002/ajmg.b.32641",
language = "English",
volume = "180",
pages = "113--121",
journal = "American Journal of Medical Genetics Part B-neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley",
number = "2",

}

Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study. / Kirli, Umut; Binbay, Tolga; Drukker, Marjan; Elbi, Hayriye; Kayahan, Bulent; Gokcelli, Duygu Keskin; Ozkinay, Ferda; Onay, Huseyin; Alptekin, Koksal; van Os, Jim.

In: American Journal of Medical Genetics Part B-neuropsychiatric Genetics, Vol. 180, No. 2, 03.2019, p. 113-121.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study

AU - Kirli, Umut

AU - Binbay, Tolga

AU - Drukker, Marjan

AU - Elbi, Hayriye

AU - Kayahan, Bulent

AU - Gokcelli, Duygu Keskin

AU - Ozkinay, Ferda

AU - Onay, Huseyin

AU - Alptekin, Koksal

AU - van Os, Jim

PY - 2019/3

Y1 - 2019/3

KW - AGE

KW - BDNF

KW - BDNF GENE

KW - BIPOLAR DISORDER

KW - CANDIDATE GENES

KW - NEUROTROPHIC FACTOR VAL66MET

KW - ONSET

KW - RECEPTOR

KW - RISK

KW - SCHIZOPHRENIA

KW - SYMPTOMS

KW - environmental factors

KW - epidemiology

KW - extended psychosis phenotype

KW - transdiagnostic psychosis phenotype

U2 - 10.1002/ajmg.b.32641

DO - 10.1002/ajmg.b.32641

M3 - Article

VL - 180

SP - 113

EP - 121

JO - American Journal of Medical Genetics Part B-neuropsychiatric Genetics

JF - American Journal of Medical Genetics Part B-neuropsychiatric Genetics

SN - 1552-4841

IS - 2

ER -